Travoprost
CAS No : 157283-68-6
General description:
Travoprost is an active pharmaceutical ingredient (API) used in the treatment of glaucoma and ocular hypertension. It is a synthetic prostaglandin F2α analog that lowers intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral pathway.
Travoprost is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for ophthalmic formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of effective eye-care therapies.
Travoprost is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for ophthalmic formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of effective eye-care therapies.
Chemical Structure:
